Johnson & Johnson $JNJ Shares Acquired by Howard Capital Management Inc.

29 Oct 2025, 07:14 by Teresa Graham · The Cerbat Gem

Howard Capital Management Inc. boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 10.3% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 18,203 shares of the company’s stock after purchasing an additional 1,693 shares during the quarter. Howard Capital Management Inc.’s holdings in Johnson & Johnson were worth $2,781,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Greenup Street Wealth Management LLC lifted its position in Johnson & Johnson by 3.1% in the 2nd quarter. Greenup Street Wealth Management LLC now owns 2,021 shares of the company’s stock valued at $309,000 after purchasing an additional 60 shares during the last quarter. Ellis Investment Partners LLC raised its position in shares of Johnson & Johnson by 0.7% during the 2nd quarter. Ellis Investment Partners LLC now owns 8,559 shares of the company’s stock worth $1,307,000 after buying an additional 62 shares in the last quarter. Cypress Wealth Services LLC raised its position in shares of Johnson & Johnson by 0.9% during the 2nd quarter. Cypress Wealth Services LLC now owns 6,634 shares of the company’s stock worth $1,013,000 after buying an additional 62 shares in the last quarter. Horizon Bancorp Inc. IN raised its position in shares of Johnson & Johnson by 11.2% during the 2nd quarter. Horizon Bancorp Inc. IN now owns 636 shares of the company’s stock worth $97,000 after buying an additional 64 shares in the last quarter. Finally, Global Strategic Investment Solutions LLC raised its position in shares of Johnson & Johnson by 3.5% during the 2nd quarter. Global Strategic Investment Solutions LLC now owns 1,925 shares of the company’s stock worth $294,000 after buying an additional 65 shares in the last quarter. 69.55% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

JNJ has been the topic of a number of recent analyst reports. Weiss Ratings upgraded shares of Johnson & Johnson from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 8th. Bank of America boosted their price target on shares of Johnson & Johnson from $198.00 to $204.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 15th. Erste Group Bank upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating in a research report on Wednesday, July 23rd. Barclays boosted their price target on shares of Johnson & Johnson from $165.00 to $176.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 17th. Finally, UBS Group boosted their price target on shares of Johnson & Johnson from $190.00 to $214.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Three equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, Johnson & Johnson currently has an average rating of “Moderate Buy” and an average target price of $199.05.

Read Our Latest Research Report on JNJ

Johnson & Johnson Stock Down 1.8%

NYSE JNJ opened at $186.94 on Wednesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80. The company’s 50 day simple moving average is $182.72 and its 200 day simple moving average is $166.92. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $194.48. The company has a market capitalization of $450.40 billion, a P/E ratio of 18.04, a PEG ratio of 2.24 and a beta of 0.40.

Johnson & Johnson (NYSE:JNJ – Get Free Report) last released its earnings results on Wednesday, August 30th. The company reported $2.26 EPS for the quarter. Johnson & Johnson had a net margin of 27.26% and a return on equity of 32.73%. The business had revenue of $24.02 billion for the quarter. Equities research analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 25th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend is Tuesday, November 25th. Johnson & Johnson’s dividend payout ratio (DPR) is 50.19%.

Insider Buying and Selling at Johnson & Johnson

In other news, EVP Jennifer L. Taubert sold 56,471 shares of Johnson & Johnson stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $177.81, for a total value of $10,041,108.51. Following the transaction, the executive vice president directly owned 178,013 shares of the company’s stock, valued at $31,652,491.53. This trade represents a 24.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.16% of the stock is currently owned by company insiders.

About Johnson & Johnson

(Free Report)